{
  "retracted": false,
  "timestamp": 1497225600000,
  "updates": [
    {
      "timestamp": 1497273017570,
      "identifier": {
        "doi": "10.1007/s10147-017-1146-6"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10147-016-1083-9"
  },
  "journal": "International Journal of Clinical Oncology",
  "publisher": "Springer Nature",
  "title": "Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer"
}
